1. Home
  2. CGTX vs MNSB Comparison

CGTX vs MNSB Comparison

Compare CGTX & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • MNSB
  • Stock Information
  • Founded
  • CGTX 2007
  • MNSB 2003
  • Country
  • CGTX United States
  • MNSB United States
  • Employees
  • CGTX N/A
  • MNSB N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • MNSB Major Banks
  • Sector
  • CGTX Health Care
  • MNSB Finance
  • Exchange
  • CGTX Nasdaq
  • MNSB Nasdaq
  • Market Cap
  • CGTX 158.8M
  • MNSB 170.1M
  • IPO Year
  • CGTX 2021
  • MNSB N/A
  • Fundamental
  • Price
  • CGTX $1.74
  • MNSB $18.31
  • Analyst Decision
  • CGTX Strong Buy
  • MNSB
  • Analyst Count
  • CGTX 3
  • MNSB 0
  • Target Price
  • CGTX $2.83
  • MNSB N/A
  • AVG Volume (30 Days)
  • CGTX 2.1M
  • MNSB 24.7K
  • Earning Date
  • CGTX 11-12-2025
  • MNSB 10-17-2025
  • Dividend Yield
  • CGTX N/A
  • MNSB 2.18%
  • EPS Growth
  • CGTX N/A
  • MNSB N/A
  • EPS
  • CGTX N/A
  • MNSB N/A
  • Revenue
  • CGTX N/A
  • MNSB $64,604,000.00
  • Revenue This Year
  • CGTX N/A
  • MNSB $23.19
  • Revenue Next Year
  • CGTX N/A
  • MNSB $2.92
  • P/E Ratio
  • CGTX N/A
  • MNSB N/A
  • Revenue Growth
  • CGTX N/A
  • MNSB N/A
  • 52 Week Low
  • CGTX $0.22
  • MNSB $15.00
  • 52 Week High
  • CGTX $3.83
  • MNSB $22.98
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 51.92
  • MNSB 21.07
  • Support Level
  • CGTX $1.67
  • MNSB $18.81
  • Resistance Level
  • CGTX $2.00
  • MNSB $19.77
  • Average True Range (ATR)
  • CGTX 0.16
  • MNSB 0.49
  • MACD
  • CGTX 0.02
  • MNSB -0.18
  • Stochastic Oscillator
  • CGTX 59.48
  • MNSB 8.10

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About MNSB MainStreet Bancshares Inc.

MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.

Share on Social Networks: